2019
DOI: 10.1016/j.jep.2019.02.031
|View full text |Cite
|
Sign up to set email alerts
|

Rhodiola rosea root extract has antipsychotic-like effects in rodent models of sensorimotor gating

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 58 publications
1
10
0
Order By: Relevance
“…R. rosea effects were recently evaluated in murine models of prepulse inhibition, an established operational measure of sensorimotor gating which is impaired in a variety of mental disorders featuring psychosis [156]. In detail, R. rosea extract robustly reverses prepulse inhibition deficits which are induced by either the dopamine D2 receptor agonist apomorphine or the NMDA receptor antagonist dizocilpine.…”
Section: Prepulse Inhibition-related Depression and Psychosismentioning
confidence: 99%
See 2 more Smart Citations
“…R. rosea effects were recently evaluated in murine models of prepulse inhibition, an established operational measure of sensorimotor gating which is impaired in a variety of mental disorders featuring psychosis [156]. In detail, R. rosea extract robustly reverses prepulse inhibition deficits which are induced by either the dopamine D2 receptor agonist apomorphine or the NMDA receptor antagonist dizocilpine.…”
Section: Prepulse Inhibition-related Depression and Psychosismentioning
confidence: 99%
“…In detail, R. rosea extract robustly reverses prepulse inhibition deficits which are induced by either the dopamine D2 receptor agonist apomorphine or the NMDA receptor antagonist dizocilpine. Thus, R. rosea may possess antipsychotic effects, though the underlying molecular mechanisms remain to be elucidated [156].…”
Section: Prepulse Inhibition-related Depression and Psychosismentioning
confidence: 99%
See 1 more Smart Citation
“…This information suggests that an antioxidant, anti-inflammatory, antidepressant and anxiolytic agent may be effective in the treatment of stress-induced infertility and pathologies affecting reproductive processes. Rhodiola rosea root extract (RRE) used in the study is obtained from the root of Rhodiola rosea L. plant [17], which grows in the northern parts of Europe, Asia and the US. Preclinical studies have reported that RRE has anti-stress, neuropsychotropic, anxiolytic, antidepressant and neuroprotective effects [17,18].…”
Section: Introductionmentioning
confidence: 99%
“…Rhodiola rosea root extract (RRE) used in the study is obtained from the root of Rhodiola rosea L. plant [17], which grows in the northern parts of Europe, Asia and the US. Preclinical studies have reported that RRE has anti-stress, neuropsychotropic, anxiolytic, antidepressant and neuroprotective effects [17,18]. In addition, Rhodiola rosea extract has antioxidant and anti-inflammatory effects [19,20].…”
Section: Introductionmentioning
confidence: 99%